Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 7/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.52 |
| ▸ | PGR | P06401 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 6/20 | 0.52 |
| ▸ | AR | P10275 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.51 |
| ▸ | USP2 | O75604 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formocortal SCHEMBL5484249 | 1.00 | HIF1A (0.52) | HIF1ANR3C1PGRLMNAAR | |
| Formocortal SCHEMBL21234455 | 1.00 | HIF1A (0.52) | HIF1ANR3C1PGRLMNAAR | |
| Formocortal SCHEMBL4354 | 1.00 | HIF1A (0.52) | HIF1ANR3C1PGRLMNAAR | |
| SCHEMBL25854502 | 0.92 | HIF1A (0.45) | HIF1ANR3C1PGRLMNAAR | |
| SCHEMBL6832364 | 0.92 | CYP3A4 (0.54) | HIF1ANR3C1PGRLMNAAR | |
| SCHEMBL5034365 | 0.92 | CYP3A4 (0.54) | HIF1ANR3C1PGRLMNAAR | |
| SCHEMBL21234457 | 0.91 | CYP3A4 (0.50) | HIF1ANR3C1PGRLMNAAR | |
| SCHEMBL21340498 | 0.90 | HIF1A (0.43) | HIF1ANR3C1PGRLMNAAR | |
| Formocortal SCHEMBL6915676 | 0.90 | HIF1A (0.43) | HIF1ANR3C1PGRLMNAAR | |
| Cicortonide SCHEMBL2110020 | 0.89 | NR3C1 (0.51) | HIF1ANR3C1PGRLMNAAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6529 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20250387493-A1 | METHOD OF ABROGATING ANTI-DRUG ANTIBODY FORMATION, AND DRUG CONJUGATES FOR USE THEREIN | ONCOC4 INC (US) | 2025-12-25 | — | — | US | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| EP-4584334-A1 | TITANIUM DIOXIDE ASPHALT COMPOSITIONS AND METHODS FOR THEIR APPLICATION | CoolSeal LLC (US) | 2025-07-16 | — | — | EP | claimed |
| US-20250205227-A1 | METHODS FOR ADMINISTERING CORTICOSTEROIDS | SPARROW PHARMACEUTICALS, INC. | 2025-06-26 | — | — | US | claimed |
| WO-2025123147-A1 | TOLERIZING IMMUNOMODULATORY COMBINATION | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2025-06-19 | — | — | WO | claimed |
| CN-120119240-A | Titanium alloy powder for strong-bonding cold spray coating and preparation method and application thereof | 西安交通大学 | 2025-06-10 | — | — | CN | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-119961631-A | Artificial intelligence persuasion task performance evaluation method based on information entropy | 中国海洋大学 | 2025-05-09 | — | — | CN | claimed |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-05-08 | — | — | US | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| WO-1997015298-A1 | COMBINATION OF LTD, RECEPTOR ANTAGONISTS WITH GLUCOCORTICOSTEROIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-05-01 | — | — | WO | claimed |
| WO-1997009067-A1 | COMBINATION OF 5-LIPOXYGENASE AND LEUKOTRIENE SYNTHESIS INHIBITORS WITH GLUCOCORTICOSTEROIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-03-13 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0173478-B1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1994-02-02 | — | — | EP | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |
| US-4970206-A | TRANSDERMAL DRUG DELIVERY | MERCK & CO., INC. (US) | 1990-11-13 | — | — | US | claimed |
| EP-0173478-A1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1986-03-05 | — | — | EP | claimed |